...
首页> 外文期刊>Journal of Medicinal Chemistry >Bis-pyranobenzoquinones as a New Family of Reversal Agents of the Multidrug Resistance Phenotype Mediated by P-Glycoprotein in Mammalian Cells and the Protozoan Parasite Leishmania
【24h】

Bis-pyranobenzoquinones as a New Family of Reversal Agents of the Multidrug Resistance Phenotype Mediated by P-Glycoprotein in Mammalian Cells and the Protozoan Parasite Leishmania

机译:双吡喃苯并醌作为哺乳动物细胞和原生动物寄生虫利什曼原虫介导的P-糖蛋白介导的多药耐药表型逆转剂的新家族。

获取原文
获取原文并翻译 | 示例
           

摘要

We have synthesized a set of bis-pyranobenzoquinones through a direct and highly efficient approach based on a double intramolecular domino Knoevenagel hetero Diels-Alder reaction. These bis-pyranobenzoquinone derivatives are compounds whose skeletons have similarities to those of some anticancerous and leishmanicidal drugs. Considering that these drugs are substrates for some members of the ATP-binding cassette (ABC) family of proteins that confers a multidrug resistance (MDR) phenotype, we have carried out the biological evaluation of 20 bis-pyranobenzoquinones as modulators of the MDR phenotype in mammalian cell lines overexpressing P-glycoprotein, MRP1, or BCRP. Moreover, we also tested some of these compounds as potential MDR modulators in a Leishmania tropica line overexpressing a P-glycoprotein-like transporter. Compounds 9 and 10 are, in this work, the most promising reversal agents of MDR in human cancer cell lines, while compounds 4 and 20 showed potent reversal activity of MDR phenotype in the protozoan parasite Leishmania.
机译:我们已经基于双分子内多米诺骨牌Knoevenagel杂Diels-Alder反应的直接和高效方法合成了一组双吡喃苯并醌。这些双吡喃并苯并醌衍生物是骨架与某些抗癌和利什曼杀菌药相似的化合物。考虑到这些药物是可赋予多药耐药性(MDR)表型的ATP结合盒(ABC)家族蛋白的某些成员的底物,我们对20种双吡喃苯醌作为MDR表型的调节剂进行了生物学评估。过度表达P-糖蛋白,MRP1或BCRP的哺乳动物细胞系。此外,我们还在过表达P-糖蛋白样转运蛋白的热带利什曼原虫系中测试了其中一些化合物作为潜在的MDR调节剂。在这项工作中,化合物9和10是人类癌细胞系中最有希望的MDR逆转剂,而化合物4和20在原生动物寄生虫利什曼原虫中显示出MDR表型的强力逆转活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号